Anti-Human CTAA16.88 Therapeutic Antibody (Votumumab)

Recombinant monoclonal antibody to CTAA16.88. Votumumab is a human monoclonal antibody labelled with the radionuclide technetium-99m. It can be potentially used in the treatment of Colorectal tumors.
Supplier Creative Biolabs
Product # TAB-466CQ
Pricing Inquiry
Host Human
Target Carcinoma associated antigen CTAA16 (complex of cytokeratin polypeptides 35-40kDa)
Species Reactivity Human
Type IgG3, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback